🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Amazing words from an amazing leader. Looking forward to a bright future

1st Patients To Get CRISPR Gene-Editing Treatment Continue To Thrive - NPR this is an incredible story. Can’t wait to offer this to the sickle cell patients we take care of that deserve and need better therapies. #sicklecell #hematology apple.news/ACtz14GzRRlq3m…

Made it through the snow for the #CovidVaccine thank you to all the hard work by scientists and clinicians to make this happen along with Dana-Farber for providing it so we can continue to provide care for our cancer patients #PfizerBioNTech

If anyone had a right to question whether our democracy was worth redeeming, it was Dr. Martin Luther King, Jr. Because in the face of billy clubs and lynchings, poll taxes and literacy tests, he never gave in to violence, never waved a traitorous flag or gave up on our country.

When you’re a T cell looking for a non-immunogenic tumor.

#ESMOTAT21 Susan Guedan provides an overview of CAR-T cell trials in solid tumors

José Baselga, MD, PhD— revered AACR Past President, Fellow of the AACR Academy, and an internationally renowned expert in the development of molecular targeted agents— has died at the age of 61. We offer heartfelt condolences to his family, colleagues, and friends. #AACRFellows

So sad. he was such a dedicated clinician and passionate researcher. Countless patients benefited from his care. May he rest in piece

U.S. Calls for Pause on Johnson & Johnson Vaccine After Clotting Cases nytimes.com/2021/04/13/us/… will have to start seeing if all the clotting consults we have been getting had recent J&J

Today, a jury did the right thing. But true justice requires much more. Michelle and I send our prayers to the Floyd family, and we stand with all those who are committed to guaranteeing every American the full measure of justice that George and so many others have been denied.

Please consider donating whatever you can in Francisco’s honor. Thank you. My Giving Page: Francisco Marty, MD, Legacy Lecture's Fundraising Page - My Fundraising Page danafarber.jimmyfund.org/site/TR?fr_id=…

In response to a recent The New York Times investigation, we have updated our position statement on #sicklecell trait and will focus on education and training to end this injustice. Read more: loom.ly/ccQapm8

#ASCO21 we are ready to go!💨 Here, some of the most interesting abstract on #LungCancer #LCSM that will be presented, very soon! Take a look at that & enjoy 👁‍🗨

Was a pleasure to work on this review with @connors_md and Bruce Tiu A comprehensive review of DOACs for cancer associated VTE prophylaxis or treatment #heme #oncology @BrighamHeme tandfonline.com/doi/full/10.10…

Tonight I will sleep easy for the first time in a long time. >500,000 single T cell transcriptomes, all publicly available. Also accepting donations after we spent all our money on this study. 🤣 Thank you so much nature! Have at it, world! 🍾🍾🍾 nature.com/articles/s4158…

🚨NEW: CAR T cells produced in vivo to treat cardiac injury #CARTCell #TCell #Tcellrx #genetherapy Penn Medicine science.org/doi/10.1126/sc…

Excellent first day at ASCO #ASCO2022 Brandon Huffman, MD Elizabeth Carstens excited to see what else is coming

Congratulations to Dr. Marla Lipsyc-Sharf, MD (Dana-Farber ⭐️ senior co-fellow) on her incredible #ASCO22 oral presentation on “Circulating tumor DNA (ctDNA) and late recurrence in high-risk, hormone receptor–positive, HER2-negative breast cancer (CHiRP)”! Simultaneous Journal of Clinical Oncology pub!

Such an amazing talk Marla Lipsyc-Sharf, MD you set the bar high for your co-fellows!